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number of proteins are recruited to nuclear foci upon
exposure to double-strand DNA damage, including
53BP1 and Rad51, but the precise role of these
DNA damage–induced foci remain unclear. Here we show
in a variety of human cell lines that histone deacetylase
(HDAC) 4 is recruited to foci with kinetics similar to, and
colocalizes with, 53BP1 after exposure to agents causing
double-stranded DNA breaks. HDAC4 foci gradually dis-
appeared in repair-proﬁcient cells but persisted in repair-
A
 
deﬁcient cell lines or cells irradiated with a lethal dose,
suggesting that resolution of HDAC4 foci is linked to repair.
Silencing of HDAC4 via RNA interference surprisingly also
decreased levels of 53BP1 protein, abrogated the DNA
damage–induced G2 delay, and radiosensitized HeLa cells.
Our combined results suggest that HDAC4 is a critical
component of the DNA damage response pathway that
acts through 53BP1 and perhaps contributes in maintaining
the G2 cell cycle checkpoint.
 
Introduction
 
A number of proteins, including 53BP1 (Schultz et al.,
2000; Anderson et al., 2001; Rappold et al., 2001; Xia et
al., 2001), Rad51, 
 
 
 
H2AX, NBS1/Mre11/Rad50 complex
(Maser et al., 1997; Paull et al., 2000), and BRCA1 (Scully
et al., 1997; Zhong et al., 1999) have been observed to accu-
mulate at multiple foci in the nucleus in response to DNA
damage. 53BP1 was first identified in a yeast two-hybrid
screen as one of two proteins that interacted with the trans-
activation domain of p53. Recently it was shown that
53BP1 participates in the phosphorylation of p53 and Chk2
and in the maintenance of S and G2 cell cycle checkpoints
after DNA damage (DiTullio et al., 2002; Fernandez-Capetillo
et al., 2002; Wang et al., 2002). 53BP1 foci are detectable
within minutes after exposure to ionizing radiation, the
number of foci increases with increasing dose, and the foci
colocalize with that of 
 
 
 
H2AX, suggesting an early role in
the DNA damage response for 53BP1, as perhaps a marker
of unrepaired double-strand breaks. Recent studies of cell
lines derived from H2AX knockout mice show that this gene
mediates radiation resistance and is essential for various
components of the DNA damage response pathway to form
foci (Bassing et al., 2002; Celeste et al., 2002). Although
these data point to a role of chromatin in the DNA damage
response, it remains unclear to what extent these foci represent
alterations of the underlying chromatin.
Chromatin undergoes expansion and compaction in the
course of many fundamental cellular processes, including
gene expression, differentiation, and cell cycle progression.
These alterations of the chromatin are largely mediated by
histone acetylases and histone deacetylases (HDACs).*
HDACs act on key acetylated lysine residues of core histones
to induce chromatin compaction, which in turn results in
gene silencing and heterochromatin formation (Taunton et
al., 1996; Yang et al., 1996; Fischle et al., 1999; Grozinger
et al., 1999). HDACs have been categorized into three
classes that are based on sequence homology and do-
main  organization. Class I HDACs (HDAC1, HDAC2,
HDAC3, and HDAC8) are similar to the yeast deacetylase
Rpd3 (Yang et al., 1996; Dangond et al., 1998; Emiliani et
al., 1998; Buggy et al., 2000; Hu et al., 2000). Class II
HDACs (HDAC4, HDAC5, HDAC6, and HDAC7) pos-
sess catalytic domains homologous to that of yeast Hda1
(Rundlett et al., 1996; Fischle et al., 1999; Grozinger et al.,
1999; Miska et al., 1999; Verdel and Khochbin, 1999;
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Wang et al., 1999; Kao et al., 2000). Proteins similar to the
yeast NAD1-dependent deacetylase Sir2 (Frye, 2000; Imai
et al., 2000; Landry et al., 2000; Smith et al., 2000) com-
pose the third class of HDACs. Class I and II HDACs have
been found to function as corepressors recruited for tran-
scriptional repression, whereas the class III HDACs are im-
portant for gene silencing at telomeres and HM (mating
type) loci in yeast (Sherman et al., 1999).
Although HDACs are most prominently linked with tran-
scriptional repression, there are indications that HDACs
may play broader roles in regulating cellular processes that
affect survival after exposure to DNA-damaging agents. For
example, p53 has been found to be deacetylated and inacti-
vated by human Sir2
 
 
 
 in mammalian cells, leading to re-
duced apoptosis and increased survival after exposure to
ionizing radiation or etoposide. Conversely, expression of
catalytically inactive Sir2
 
 
 
 leads to increased apoptosis and
radiosensitization in mammalian cells (Luo et al., 2001;
Vaziri et al., 2001). Effects of the class III HDACs may ex-
tend beyond effects on p53. In budding yeast, members of
the SIR2 family of HDACs appear to be important compo-
nents of the DNA damage pathway. Whereas SIR2 appears
to be static, SIR3 and SIR4 are mobilized to sites of DNA
breaks (Gottschling et al., 1990; Tsukamoto et al., 1997;
Martin et al., 1999; Moazed, 2001). SIR2, SIR3, and SIR4
are required for the efficient recircularization of linear plas-
mids by nonhomologous end joining, and mutations in
these genes resulted in increased sensitivity to 
 
 
 
-radiation in
fission yeast (Boulton and Jackson, 1998; Tsukamoto et al.,
1997). A role in the DNA damage response has not yet been
described for the class I and II HDACs, but is suggested by
the observation that treatment with the class I and II HDAC
inhibitor trichostatin A (TSA) leads to significant radiosensi-
tization of human cells (Biade et al., 2001) (the class III Sir2
family deacetylases are resistant to TSA [Bernstein et al.,
2000]). The mechanism of how TSA might lead to radio-
sensitization has likewise been unclear.
To assess for a role for class I and II HDACs in the DNA
damage response in human cells, we examined several mem-
bers for their ability to form foci in response to DNA dam-
age. After exposure to double-strand DNA damage in a vari-
ety of human cells, we found that human HDAC4 is
recruited to nuclear foci with kinetics similar to 53BP1. We
found that HDAC4 and 53BP1 colocalize at foci and could
be coimmunoprecipitated. HDAC4 foci formation was seen
in a wide variety of cell lines, which included radiosensitive
cell lines lacking the gene products of ATM (ataxia telangi-
ectasia mutated), Nibrin, and DNA protein kinase (DNA-
PK). HDAC4 foci disappeared after several hours in re-
pair-proficient cells that were exposed to nonlethal doses of
radiation. However, HDAC4 foci failed to resolve in radio-
sensitive cell lines or in normal cells that were exposed to a
lethal dose of radiation. Silencing of HDAC4 resulted in de-
creased 53BP1 protein levels and did not markedly affect
cell cycle distribution in unirradiated cells, but markedly ab-
rogated the G2 checkpoint in radiosensitized cells after
DNA damage. These results together suggest that HDAC4
is a critical component of the DNA damage response path-
way and suggests an additional role for this protein beyond
transcriptional silencing.
 
Results
 
HDAC4 is recruited to nuclear foci after exposure to 
double-strand DNA damage
 
To investigate a potential role of HDACs in the DNA dam-
age response in human cells, we studied the response of
HDAC2, 4, and 6 to DNA damage. HeLa cells exposed to
 
 
 
-irradiation (IR) or etoposide exhibited distinct foci of
HDAC4 in their nucleus (Fig. 1, B and D), whereas unirra-
diated (Fig. 1 A) or UV exposure did not have this effect
(Fig. 1 E). In contrast, DNA damage did not induce foci
formation by HDAC2 (Fig. 1 I) or HDAC6 (Fig. 1 J) or no-
ticeably alter their intracellular localization. We observed
IR-induced HDAC4 foci in both transformed and untrans-
formed cell lines, including the breast cancer cell lines
MCF7, PA1, SKBR, and MO59J and K (both of gliomatous
origin), the sarcoma cell lines U20S, HT29, and HT1080
(latter two are colon cancer lines), and Wi38 and WSC
Figure 1. Recruitment of HDAC4 to nuclear foci after double-strand 
DNA damage. HeLa cells that were (A) unirradiated, (B) irradiated 
with 2 Gy, (C) irradiated and probed with secondary antibody only, 
(D) irradiated and probed with primary antibody (anti-HDAC4) 
immunodepleted with the immunizing antigen. (E) HeLa cells 
exposed to UV (50 J/m
2) and (F) 20  M etoposide were fixed after 1 h 
and stained with HDAC4 antibodies. (G and H) DAPI stain of cells 
in E and F, respectively, were merged with HDAC4. Cells irradiated 
with 2 Gy were stained for (I) HDAC2 and (J) HDAC6. All staining 
of irradiated cells was performed 1 h after IR. Bar, 5  m.T
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(normal human fibroblasts) (unpublished data). Thus, foci
formation by HDAC4 in response to DNA damage appears
to be a general cellular response that does not appear to be
dependent on p53.
The formation of HDAC4 foci after exposure to DNA
damage was not accompanied by significant changes in
HDAC4 deacetylase activity or protein levels (Fig. 2, A and
B). We noted however a dose-dependent increase in the av-
erage number of HDAC4 foci per cell (Fig. 2 C). IR re-
sulted in approximately 30 foci per Gy up to 3 Gy, beyond
which the increase in the number of foci with increasing
dose was difficult to discern. Kinetics of foci formation was
 
the same between cells exposed to nonlethal (1 Gy) and le-
thal (8 Gy) doses (Fig. 2 D). HDAC4 foci were evident
within 5 min after IR and reached a maximum by 1 h. In-
terestingly, the number of foci in cells irradiated with 1 Gy
progressively decreased to background levels by 24 h after
IR. In contrast, the majority (87 
 
 
 
 7%) of HeLa cells irra-
diated with 8 Gy retained their HDAC4 foci as long as 48 h
after IR. Foci were evident beyond 48 h when there was a
high level of cell death (unpublished data). The persistence
of HDAC4 foci therefore appears to correlate with lethal
doses of IR, which presumably result in accumulation of
unrepaired DNA.
Figure 2. Dose and time dependency 
of DNA damage–induced HDAC4 foci. 
(A) HDAC4-associated deacetylase 
activity is not appreciably changed by IR. 
HDAC4 or Ncor was immunoprecipitated 
from HeLa lysates and assayed for 
deacetylase activity. Ncor and HDAC4 
treated with TSA serve as positive and 
negative controls, respectively, for the 
deacetylase assays. (B) HDAC4 levels do 
not change after IR. Equal amounts of 
total protein (25  g) from HeLa cells 
were separated via 4–20% gradient 
SDS-PAGE, transferred to nitrocellulose, 
and probed with rabbit preimmune 
serum (left), anti-HDAC4 (right), or 
anti– -tubulin antibody (loading control) 
(bottom). Mock-irradiated ( IR) or 
irradiated ( IR) cells were harvested 1 h 
after 3 Gy. (C) HDAC4 foci formation is 
dependent on the dose of IR. HeLa cells 
exposed to increasing doses of IR were 
fixed after 1 h and stained for HDAC4 
foci. At least 100 cells were counted for 
each dose. Error bars represent the SD, 
and each point represents the average of 
three experiments. (D) Kinetics of HDAC4 
foci formation. HeLa cells irradiated 
with 1 and 8 Gy were fixed at various 
times, and the average number of cells 
showing induced HDAC4 foci was 
counted. Time is depicted on a log scale. 
(E) Comparison of the kinetics of foci 
formation amongst HDAC4, 53BP1, and 
Rad51. HeLa cells were irradiated (3 Gy), 
fixed at the indicated times, and separately 
stained for HDAC4, 53BP1, and Rad51 
foci. Error bars represent the SD, and each 
point represents the average of three 
experiments. (F) Coimmunoprecipitation 
of HDAC4 and 53BP1. HeLa cells were 
lysed in NETN buffer (150 mM NaCl, 
1 mM EDTA, 20 mM Tris, pH 8, 0.5% 
NP-40) and, for each sample, 50  g of 
lysate from unirradiated (IR ) or irradiated 
cells (IR ) was incubated with the 
indicated antibodies or preimmune 
serum (IP). The immunoprecipitates 
were separated on 7.5% SDS-PAGE gels 
and probed for 53BP1 (top) and HDAC4 
(bottom) (IB). Total cell lysate (25  g, 
Whole cell) served as a positive control 
for the immunoblots. (G) Colocalization of HDAC4 foci relative to 53BP1 and Rad51 foci. HeLa cells were irradiated with 3 Gy and 1 h later 
costained with (a) rabbit anti-HDAC4 and (b) rat anti-53BP1. (c) Images from A and B were merged to reveal that most foci were coincident. 
The nuclei are outlined in blue. Bar, 5  m.T
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HDAC4 interacts with 53BP1
 
DNA damage induces 53BP1 to form foci within minutes
after DNA damage, suggesting that they participate in the
early steps of the DNA damage response pathway. In con-
trast, Rad50 and Rad51 foci appear hours after DNA dam-
age (Paull et al., 2000). We found that HDAC4 formed foci
with kinetics very similar to 53BP1. The average number of
foci containing either 53BP1 or HDAC4 reached maximal
levels by 1 h after 3 Gy and then progressively decreased to
near baseline by 36 h (Fig. 2 E). The similarity in the kinet-
ics of HDAC4 and 53BP1 foci formation motivated us to
look further for interactions between HDAC4 and 53BP1.
Immunoprecipitation experiments showed that HDAC4
and 53BP1 formed a complex in HeLa cells, but the forma-
tion of this complex was unaffected by DNA damage (Fig. 2
F). However, immunocytochemical data clearly showed that
HDAC4 and 53BP1 colocalized at DNA damage–induced
foci (Fig. 2 G). At later times after radiation when Rad51
foci began to accumulate, the numbers of HDAC4 and
53BP1 foci were reduced. The majority of Rad51 foci did
not colocalize with HDAC4, although it may be possible
that Rad51 was localized to sites that had previously been
 
occupied by HDAC4 (see Figs. S1 and S2, available at http:
//www.jcb.org/cgi/content/full/jcb.200209065/DC1).
 
HDAC4 foci induced by IR persist in radiosensitive cells
 
We next examined in a range of human cell lines the genetic
determinants that specified HDAC4 foci formation. We
found that HDAC4 foci formation did not depend on DNA
damage response genes, i.e., ATM (ataxia telangiectasia mu-
tated), Nibrin, or DNA-PK, as cell lines defective for these
genes formed foci with similar kinetics as HeLa cells (Fig. 3).
However, the repair-deficient cell lines differed from HeLa
(and other repair-proficient) cells in the persistence of
HDAC4 foci after exposure to low doses of IR. For example,
HDAC4 foci readily formed 1 h after radiation in the ATM-
deficient FT169 cell line, as well as in its isogenic derivatives
Y25 (in which ATM is restored by expression of a full-length
cDNA) and PEB (expressing empty vector and hence re-
maining ATM deficient). 24 h after IR, HDAC4 foci were
significantly reduced only in the ATM-positive Y25 cells
(Fig. 3, A–D). A similar difference in the resolution of
HDAC4 foci was observed between DNA-PK–deficient
MO59J cells and DNA-PK–positive MO59K cells. Al-
Figure 3. DNA repair–deficient cell lines are 
unable to efficiently resolve HDAC4 foci. Cells 
deficient for ATM, DNA-PK, and Nibrin were 
exposed to 1 Gy of IR and fixed and stained for 
HDAC4 1 and 24 h after IR. The average percentage 
of each cell line showing IR-induced HDAC4 was 
determined and the data presented in a histogram. 
Representative images of the HDAC4 staining 
pattern in the respective cell lines 24 h after IR 
are presented in the right panels. (A) 1 h after IR 
(1 Gy), respectively 95   4.3% and 89   4.0% of 
ATM-deficient FT169A and ATM-restored Y25 
cells showed induced foci, a difference that was 
statistically insignificant. In contrast, 24 h after IR, 
respectively 82   3.1% and 33   5.9% of FT169A 
and Y25 cells showed induced foci (P   0.001). 
PEB cells, derived from FT169A cells via stably 
transfecting with the empty parental vector (and 
which remain deficient for ATM protein and 
radiosensitive) continued to show high levels of 
induced HDAC4 foci after IR. Representative 
images of (B) FT169A (ATM ), (C) Y25 (ATM ), 
and (D) PEB (ATM control) cell lines 24 h after 
IR. (E) 1 h after IR, respectively 93   6.7% and 
95   3.4% of DNA-PK–deficient MO69J and 
DNA-PK–proficient MO59K cells showed induced 
foci, a difference that was not significant. In 
contrast, 24 h after IR, respectively 86   10.5% 
and 40   9.6% of MO59J and MO59K showed 
induced foci (P   0.001). Representative images of 
(F) MO59J (DNAPK ) and (G) MO59K (DNAPK ) 
cells 24 h after IR. In the MO59K cells with persistent 
foci, the number of foci per cell was also consistently 
fewer than in the MO59J cells (average of 11   3.1 
vs. 45   3.7 foci, respectively, per MO59K vs. 
MO59J cell; P   0.001). (H) Nibrin-deficient cells 
(NBS ) showed high levels of HDAC4 foci at both 
1 (95   5.4% of cells) and 24 h (83   2.6%) after 
IR. In contrast, respectively 89   2.4% and 9   3.1% of HeLa cells (HeLa) showed foci. TSA treatment of HeLa cells (HeLa   TSA) did not 
prevent foci formation, but inhibited their resolution (93   4.5% and 31   14.5% of HeLa cells pretreated with TSA showed foci at 1 and
24 h after IR). Representative images of (I) Nibrin-deficient (NBS ), (J) HeLa (HeLa), and (K) HeLa cells pretreated with TSA (HeLa   TSA)
24 h after IR. Bar, 5  m. Data represent the average of three experiments. The nuclei are outlined in blue. Error bars indicate the SD.T
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though MO59K cells did not completely resolve their
HDAC4 foci, the average number of foci was less than in the
MO59J cells (Fig. 3, E–G). We believe that MO59K cells
did not efficiently resolve HDAC4 foci because of their in-
herent radiosensitivity relative to HeLa cells (Wang et al.,
1997; unpublished data), which efficiently resolves foci at
low doses of IR (Fig. 3 J). Lastly, we examined HDAC4 foci
formation in the radiosensitive Nijmegen breakage syndrome
(NBS) mutant cell lines and found that they too retained
high levels of foci 24 h after IR (Fig. 3, H and I). We found
that foci formation by HDAC4 in HeLa cells was unimpeded
by TSA. However, the resolution of HDAC4 foci in HeLa
cells was partially inhibited by TSA (Fig. 3, H and K).
 
HDAC4 foci are detected in interphase cells
 
HDAC4 foci were induced by DNA damage in nearly all
cells, suggesting it was not limited to a specific phase of the
cell cycle. We sought to confirm this in both asynchronous
and synchronized HeLa cells (Fig. 4 A). Using cyclin E ex-
pression to distinguish G1–S from G2 cells, we found IR-
induced HDAC4 foci in both. Next, we irradiated synchro-
nized cells in S phase and then harvested when cells were
beginning to progress into G2 (Fig. 4 B) or mitosis (Fig. 4
C). The average number of foci per cell was not decreased in
the G2 cells but, interestingly, was decreased in prophase
cells and not evident in mitotic cells (Fig. 4 D). These obser-
vations, however, do not permit us to distinguish whether
HDAC4 foci form less efficiently in mitotic cells or whether
the foci resolve as cells enter mitosis.
 
Silencing of HDAC4 expression via RNA interference 
(RNAi) results in decreased 53BP1 protein
 
To assess further the functions of HDAC4, we silenced its
expression by RNA interference (RNAi) (Elbashir et al.,
Figure 4. HDAC4 foci are induced by IR in interphase cells. (A) Asynchronous HeLa cells were irradiated with 2 Gy IR and 1 h later were 
fixed and stained for HDAC4, cyclin E, and DAPI. The top panels show HDAC4 staining, and the bottom panels show HDAC4 merged with 
cyclin E and DAPI. HDAC4 foci are apparent in cells in late G1/early S phase (G1–S) as well as in those not expressing cyclin E and presumably 
in G2 phase (G2). (B) Cells synchronized and mock irradiated or irradiated (2 Gy) in late S phase were fixed and stained 3 h later for HDAC4, 
cyclin B1, and DAPI. The top panels show HDAC4 staining, and the bottom panels show HDAC4 merged with cyclin B1 and DAPI. After 
mock IR (No IR), S-phase cells have not yet expressed cyclin B1 (S), whereas cyclin B1 is cytoplasmic in G2 cells (G2) and coincides with the 
condensed chromatin in mitotic cells (M) (Kao et al., 1997; Hagting et al., 1999). After IR (IR, 3 h), HDAC4 foci are seen in most cells, including 
S phase (S) and those that have progressed to and blocked in G2 phase (G2). (C) Synchronized cells were irradiated in late S phase as in B, but 
fixed 5 h after IR (IR, 5 h). Most cells remain in G2, as indicated by cytoplasmic cyclin B1. However, a few cells have progressed into prophase, 
as indicated by the entry of cyclin B1 into the nucleus (arrowhead); in these cells, the HDAC4 foci are fewer and less distinct. Bar, 5  m. 
(D) Average number of IR-induced HDAC4 foci at each position of the cell cycle. At least 100 cells were counted for each data point, and the 
experiment was repeated three times with similar results. Error bars represent the SD.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
1022 The Journal of Cell Biology 
 
|
 
 
 
Volume 160, Number 7, 2003
 
2001). We found that short interfering RNA (siRNA) di-
rected against two regions of HDAC4 efficiently repressed
levels of HDAC4 protein at 48 h after transfection. A con-
trol siRNA that was unrelated to HDAC4 had no effect
(Fig. 5 A). We conducted a time course experiment to deter-
mine the optimal time when HDAC4 expression was at its
lowest after siRNA treatment. Considerable amounts of
HDAC4 protein were detectable 12 h after transfection, but
the level of protein progressively decreased such that very lit-
tle HDAC4 protein was detectable by 36 h, indicating that
Figure 5. RNAi efficiently silences HDAC4 and 53BP1 protein expression. (A) HeLa cells were transfected with siRNA targeting two different 
sequences in HDAC4 or control siRNA, harvested 36 h later, and immunoblotted for HDAC4 and  -tubulin (loading control). Whole cell lysates 
from untransfected cells serve as a positive control. (B) Time course of HDAC4 siRNA–mediated silencing of protein expression. Parallel plates 
of HeLa cells were treated with HDAC4 siRNA and harvested at the times indicated. All lysates were separated on 7.5% SDS-PAGE and 
immunoblotted for HDAC4 or  -tubulin, indicating maximal silencing of the targeted HDAC4 protein by 36 h. (C and D) HDAC4 siRNA 
diminishes foci formation after IR. HeLa cells were treated with oligofectamine only, control siRNA, or HDAC4 siRNA and irradiated 36 h 
later with 2 Gy. 1 h after IR, the cells were fixed and immunofluorescence for HDAC4 was performed. Representative cells are shown in C. 
The number of HDAC4 foci found in each cell was counted. At least 300 cells were counted for each treatment group. (D) The average number 
of HDAC4 foci per cell after IR for each treatment group is displayed in the histograms. (E) HDAC4 and 53BP1 siRNA silence expression of 
their targeted protein, as well as each other. HeLa cells were transfected with HDAC4 or 53BP1 siRNA and harvested 48 h later. Lysates were 
separated on SDS-PAGE and immunoblotted for 53BP1, HDAC4, and  -tubulin. (F) siRNA-mediated silencing of 53BP1 and HDAC4 protein 
expression is achieved by 24 h after treatment. Parallel plates of HeLa cells were transfected with 53BP1 siRNA and harvested at the indicated 
times after transfection. Cell lysates were separated by 7.5% SDS-PAGE and immunoblotted with anti-53BP1, HDAC4, and  -tubulin antibodies. 
(G) HDAC4 and 53BP1 siRNA reduce only their target mRNA. RT-PCR was performed on total mRNA extracted from HeLa cells 48 h after 
treatment with control, HDAC4, or 53BP1 siRNA. RT-PCR was performed in parallel under identical conditions using primer pairs targeting 
53BP1, HDAC4, or GADPH (as control), and the final product was separated via electrophoresis in ethidium bromide–labeled agarose and 
photographed under UV illumination. Each RT-PCR reaction yielded a single band as shown. (H and I) HDAC4 siRNA diminishes 53BP1 foci 
formation after IR. HeLa cells were transfected with oligofectamine control, HDAC4 siRNA, control siRNA, or 53BP1 siRNA and irradiated 36 h 
later with 2 Gy. 1 h after IR, the cells were fixed, immunofluorescence for 53BP1 was performed, and the average number of foci per cell was 
determined and displayed in the histograms in H. Representative cells are shown in I.T
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it is optimal to assess silencing after 24 h (Fig. 5 B). We next
examined the effect of the HDAC4 siRNA on foci forma-
tion after IR. As expected, HDAC4 foci formation after
IR was substantially reduced with both HDAC4 siRNAs,
whereas the control siRNA had no effect (Fig. 5, C and D).
We next explored the effect of silencing HDAC4 expression
on 53BP1 and were surprised to find that 53BP1 levels were
reduced in cells transfected with HDAC4 siRNA (Fig. 5 E).
We conducted the converse experiment and found that silenc-
ing 53BP1 also led to a reduction of HDAC4. These effects
were not seen with a control siRNA. We conducted a time
course experiment with both HDAC4 and 53BP1 siRNA and
found that levels of either target protein were substantially de-
creased 24 h after treatment with either siRNA, whereas levels
of an unrelated protein (tubulin) were unaffected (Fig. 5 F).
To exclude the possibility that the HDAC4 and 53BP1 si-
RNAs inadvertently precipitated the degradation of 53BP1
and HDAC4 mRNAs, respectively, we assessed the levels of
endogenous HDAC4 and 53BP1 mRNA after siRNA treat-
ment. We found that each siRNA reduced only its target
mRNA (Fig. 5 G). Thus, the stabilities of HDAC4 and
53BP1 proteins are dependent on each other. Consistent with
the observed reduction in protein expression, cells treated
with 53BP1 or HDAC4 siRNA showed a dramatic reduction
in 53BP1 foci in response to DNA damage (Fig. 5, H and I).
Together, these experiments further suggest that HDAC4 in-
teracts in the DNA damage response pathway that involves
53BP1, perhaps as components of the same protein complex.
 
Silencing of HDAC4 expression via RNAi results in 
decreased cell viability
 
We further studied the effects of silencing HDAC4 on cell
cycle distribution and cellular viability after DNA damage.
Treatment with HDAC4 siRNA did not appear to have a
major effect in altering the cell cycle distribution of unirradi-
ated HeLa cells, compared with cells treated with control
siRNA (Fig. 6, A and B) or untreated cells (unpublished
data). IR of HeLa cells treated with control siRNA resulted
in the expected accumulation of cells in G2, characteristic of
the IR-induced checkpoint. In contrast, treatment with
HDAC4 siRNA markedly decreased the proportion of cells
with G2/M DNA content but was accompanied by an in-
crease in cells with DNA content less than 2N (sub-G1)
(Fig. 6, A and B). This reduction in G2/M cells was not due
to an S-phase delay because HDAC4 siRNA did not affect
normal S-phase progression, as determined by FACS
 
®
 
 analy-
sis and BrdU incorporation (unpublished data). Flow cy-
tometry based on DNA content alone does not distinguish
between cells in G2 and mitosis. We therefore performed
immunofluorescence on irradiated cells that were transfected
with control and HDAC4 siRNA. Control cells were
blocked in G2 after IR, as determined by high cyclin B1 lev-
els in the cytoplasm, CENP-F distributed uniformly in the
nucleus, and uncondensed chromatin (Fig. 6, C and D), as
described previously (Liao et al., 1995; Kao et al., 2001). In
contrast, few of the HDAC4 siRNA–treated cells appeared
to be in G2. Although many of these cells still retained cy-
clin B1 and CENP-F staining, the cyclin B1 was often not
uniformly cytoplasmic, the CENP-F staining of the nuclei
was frequently uneven, and many of nuclei were condensed
or fragmented. Many of these condensed cells (
 
 
 
70%), in
fact, showed high levels of phosphohistone H3 staining,
along with cyclin B1, suggesting progression into mitosis
(see Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200209065/DC1). These observations together sug-
gest that cells silenced for HDAC4 do not maintain a uni-
form G2 delay after IR. One notes, however, that as 53BP1
has been established to mediate the damage-induced G2
checkpoint, the abrogation of this checkpoint by silencing
HDAC4 may be mediated, at least in part, through decreas-
ing 53BP1 protein (DiTullio et al., 2002; Fernandez-Cape-
tillo et al., 2002; Wang et al., 2002).
To further explore the effects on cellular viability of si-
lencing HDAC4 and 53BP1, we performed clonogenic as-
says to assess the effect on the survival of HeLa cells after
DNA damage. Silencing of HDAC4 and 53BP1 had a dra-
matic effect on the plating efficiency of the cells (Fig. 6 E),
indicating that HDAC4 and 53BP1 are likely key determi-
nants of cell proliferation. However, even after correcting for
the reduced plating efficiency of these cells, silencing of
HDAC4 and 53BP1 further radiosensitized these cells (Fig.
6 F), with 53BP1 having the larger effect of the two. To-
gether, these results suggest that HDAC4 and 53BP1 are re-
quired for cells to maintain in G2 after ionizing radiation;
when either protein expression is silenced, cells do not block
in G2, but instead rapidly lose viability.
Lastly, we examined whether abrogation of the G2 delay
occurs when HDACs other than HDAC4 are silenced. Si-
lencing of HDAC2 and HDAC6 did not interfere with the
cell’s ability to arrest in G2 in response to DNA damage
(Fig. 7, A and B). Only silencing of HDAC4 appreciably di-
minished the proportion of cells delayed in G2 after IR.
 
Discussion
 
Our studies have revealed a new role for a HDAC in the
DNA damage response pathway. In response to double-
stranded DNA breaks, HDAC4, but not HDAC2 or 6, rap-
idly formed foci that are coincident with the DNA damage re-
sponse protein 53BP1. Foci formation by HDAC4 occurred
throughout interphase and was observed in a wide panel of tu-
mor and normal cell lines. HDAC4 foci formation did not
depend on DNA damage response genes ATM, DNA-PK, or
NBS, but their resolution was greatly delayed or blocked in
these mutant cell lines. This is similar to the finding that
ATM is not required for foci formation by 53BP1. When
HeLa cells were exposed to a nonlethal dose of IR, where cells
are presumably able to repair damaged DNA, HDAC4 foci
were efficiently resolved. However, at lethal doses, where cells
are presumably unable to effectively repair all of the damaged
DNA, the HDAC4 foci persisted. We believe that the effi-
ciency of resolution of HDAC4 foci correlates with cellular
radiosensitivity. DNA-PK–defective MO59J cells are highly
radiosensitive and were much less efficient at resolving their
HDAC4 foci than DNA-PK–positive MO59K cells. MO59K
cells, more radiosensitive than HeLa cells, were in turn less ef-
ficient at resolving foci than HeLa cells. The failure to resolve
HDAC4 foci may reflect the radiosensitizing properties of
TSA. These observations together suggest that HDAC4 foci
formation is a general cellular response to DNA damage, andT
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conversely, impaired resolution of HDAC4 foci may be corre-
lated with radiosensitivity.
These data suggest that HDAC4 foci may facilitate re-
cruitment of, or stabilize, repair factors such as 53BP1,
which in turn may help maintain damage-induced cell cycle
checkpoints. The interaction between HDAC4 and 53BP1
is established here by the findings that the two proteins colo-
calize and coimmunoprecipitate, as well as the unexpected
Figure 6. Silencing of HDAC4 expression abrogates the DNA damage–induced G2 checkpoint and decreases cell viability. HeLa cells were 
transfected with control or HDAC4 siRNA, followed 36 h later by mock (No IR) or 5-Gy IR (IR). 8 h after IR, parallel plates of cells were 
harvested, and cell cycle distribution was analyzed via flow cytometry (A and B) or immunofluorescence (C and D). (A) Silencing of HDAC4 
does not have a large effect on unirradiated cells, but it reduced the proportion of irradiated cells with G2/M DNA content. Cells with DNA 
content less than G1 cells (sub-G1) likely represent apoptotic cells/cell debris, and is especially apparent in cells silenced for HDAC4 and 
irradiated. (B) Histograms showing cell cycle distribution data from A, indicating the percentage of cells in each part of the cell cycle. The 
experiment was repeated three times with similar results. (C and D) To better distinguish the proportions of the total population of G2 cells, 
cells were stained for cyclin B1, CENP-F, and DAPI and analyzed via immunofluorescence. G2-phase cells show cytoplasmic cyclin B1 staining, 
diffuse nuclear CENP-F staining, and uncondensed chromatin (stained with DAPI) (Liao et al., 1995; Kao et al., 2001). (C) For each pair of 
images, the left panel shows cyclin B1 or CENP-F staining, and the right panel shows the same cells stained with DAPI. Cells treated with 
control siRNA show cytoplasmic cyclin B1 and nuclear CENP-F staining, indicative of the IR-induced G2 checkpoint. In contrast, few HDAC4 
siRNA–treated cells were blocked in G2, but instead showed fragmented and condensed chromatin that retained cyclin B1 and CENP-F staining. 
(D) Histogram showing the distribution of CENP-F staining cells with uncondensed (G2 blocked) versus condensed or fragmented chromatin 
after IR of cells treated with control or HDAC4 siRNA. At least 300 cells were counted for each experiment. (E) Histogram showing plating 
efficiency of untreated controls or cells treated with control, HDAC4, or 53BP1 siRNA. Cells were plated onto fresh dishes with fresh media 
48 h after siRNA treatment, and the proportion of surviving cells capable of excluding Trypan blue was determined 12 h later. The experiment 
was repeated three times with similar results. Error bars indicate the SD. (F) Survival curves indicating the radiosensitivity of control cells or 
cells treated with control, HDAC4, or 53BP1 siRNA. Cells were prepared as in E and irradiated with the doses indicated, and the proportion of 
surviving colonies was determined 2 wk later. All values were corrected for the plating efficiency. Error bars indicate the SD.T
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findings that siRNA-mediated silencing of HDAC4 leads to
reduced levels of 53BP1 protein and vice-versa. Thus, the
stability of each protein appears to depend on the stability of
the other, or on being associated in a common complex.
Our findings that silencing of HDAC4 expression abrogates
the damage-induced G2 delay and increases radiosensitivity
support the notion that the checkpoint determines the abil-
ity of the cell to survive radiation damage. Along with
53BP1, localization of HDAC4 to unrepaired damage may
signal the cell to stall at a checkpoint to allow the repair to
be completed, while possibly serving as a marker to facilitate
repair. These results, therefore, may be consistent with the
model proposed by Fernandez-Capetillo et al. (2002) in
which 53BP1 and other factors capable of signal transduc-
tion may accumulate into a chromatin microenvironment
within megabases of an actual DNA double-strand break.
This localized concentration of protein complexes may then
 
generate the amplification of signal sufficient to invoke the
G2 checkpoint.
These findings do not exclude roles for HDAC4 in mediat-
ing other cellular functions. HDAC4 is an established compo-
nent of complexes mediating transcriptional repression (Guen-
ther et al., 2001; Fischle et al., 2002). Although transcription is
globally decreased during mitosis (Spencer et al., 2000;
Pflumm, 2002), it appears unlikely that the role of HDAC4 in
the DNA damage response is restricted to transcriptional re-
pression. Radiation, at the doses used in this study, does not
globally repress transcription (Maity et al., 1995), and drugs
that globally inhibit transcription, such as 
 
 
 
-amanitin, do not
reverse the effects of silencing HDAC4 (unpublished data).
The radiation dose dependency of the number of HDAC4 and
53BP1 foci does not exclude, but does reduce, the likelihood
that foci are mere storage sites for these proteins.
The recruitment of HDACs to sites of DNA damage may
be at least partially evolutionarily conserved. Members of the
SIR2 family of HDACs have been implicated in the DNA
response in budding yeast, contributing either directly or in-
directly to the repair of double-strand breaks (Astrom et al.,
1999; Bennett et al., 2001). Whereas SIR2 has been most
prominently implicated in the silencing of chromatin at the
mating type loci and at telomeres, SIR3 is recruited to sites
of DNA damage to form foci that are visible at the cytologi-
cal level. It has been proposed that the accumulation of
some of these deacetylases may induce a repressed chromatin
state to facilitate repair or protect unrepaired broken DNA
ends (Tsukamoto et al., 1997; Martin et al., 1999). Al-
though HDAC4 does not belong to the same family of
deacetylases, we propose that HDAC4 may perform an anal-
ogous function in mammalian cells. As a component of pro-
tein complexes that mediate transcriptional repression by in-
ducing heterochromatin formation, HDAC4 likely serves a
similar role in processing chromatin in the DNA damage re-
sponse. Recruitment of HDAC4 to foci after DNA damage
might reflect its role in silencing the chromatin near the site
of damage. The silenced chromatin would prevent processes
such as DNA replication and transcription from passing
through damaged DNA. In addition, the silenced chromatin
might also reduce nonspecific end joining of broken DNA
ends or unwanted recombination events.
In linking a HDAC with the DNA damage response to
agents inducing double-strand breaks, the results presented
here may also have clinical implications for treating patients
with cancer. Inhibitors of HDAC inhibitors have entered
clinical trials with reports of efficacy in certain tumors
(Piekarz et al., 2001; Sandor et al., 2002). These protocols
have largely entailed administering the HDAC inhibitor as a
single agent. With further development and confirmation,
the observations reported here suggest that it may be fruitful
to pursue strategies to block HDAC function in combina-
tion with standard treatments, such as radiation and chemo-
therapy, to maximize the killing of cancer cells.
 
Materials and methods
 
Antibodies
 
Polyclonal antibodies were generated by using full-length human HDAC2,
4, and 6 expressed in bacteria to immunize rabbits. For each antigen, the
Figure 7. Silencing of HDAC2 and HDAC6 does not abrogate the 
G2 checkpoint. Parallel plates of cells were treated with control, 
HDAC2, HDAC4, or HDAC6 siRNA. 36 h after siRNA treatment, 
cells were irradiated (5 Gy) and harvested 8 h later for immunoblotting 
(A) and cell cycle analysis by FACS
® (B). (A) Immunoblot of cell 
lysates from cells treated with siRNA. Cell lysates were separated on 
7.5% SDS-PAGE, transferred onto nitrocellulose, and the membranes 
were probed with anti-HDAC4, HDAC6, HDAC2, Mad1, or  -tubulin 
antibodies. These show efficient silencing of the target proteins by 
the HDAC2, 4, and 6 siRNA. Mad1 and  -tubulin are not affected 
by the specific siRNA treatments and serve as loading controls. 
(B) Cell cycle distribution of treated cells. Cell cycle analysis shows 
that the silencing of HDAC4 protein had the most conspicuous 
effect on abrogation of the G2 checkpoint after IR, relative to silencing 
of HDAC2 and HDAC6.T
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antibody was purified from at least two rabbits and confirmed to have
equivalent specificity. The serum was affinity purified using protein immo-
bilized on Affigel beads (Bio-Rad Laboratories). Specificity of the antibody
was further confirmed by preabsorbing purified antibody with the immu-
nizing antigen (Fig. S4, available at http://www.jcb.org/cgi/content/full/
jcb.200209065/DC1). Anti-53BP1 antibody was generated against the cor-
responding domain in human 53BP1 encoded by the 1.5-kb HindIII–EcoRI
fragment of XL53BP1 (the 53BP1 cDNA was a gift from Y. Adachi, Univer-
sity of Edinburgh, Edinburgh, UK). Anti-HDAC4, anti-53BP1, anti-Mad1
(gift from M. Campbell, Yen lab), anti–CENP-F (Yen lab), anti–
 
 
 
 tubulin
(Sigma-Aldrich), and anti–cyclin B1 (BD Biosciences) were used at 1:1,000
for staining and/or immunoblotting. Anti–cyclin E (HE12, sc-247; Santa
Cruz Biotechnology, Inc.) and anti-Rad51 antibody (rabbit polyclonal, cat-
alog no. PC130, Oncogene Research Products; mouse monoclonal,
RAD51–14B4, GeneTex) was used at 1:500. The anti–phosphohistone H3
antibody recognizes histone H3 phosphorylated on serine 10 (no. 06–570;
Upstate Biotechnology) and was used at 1:1,000. Cells were fixed with
methanol/acetone 50:50 at the indicated times after IR before staining with
the respective antibodies.
 
Cell lines
 
All cells were grown in DME medium supplemented with 20% FBS at
37
 
 
 
C with 5% CO
 
2
 
. The ATM-deficient FT169A (ATM
 
 
 
), ATM-restored
YZ5 cells (ATM
 
 
 
, consisting of FT169A transfected with and stably ex-
pressing full-length ATM), and ATM-deficient vector-control PEB cells
(ATM control, consisting of FT169A cells transfected with the parental
vector only) were provided by Y. Shiloh (Tel Aviv University, Ramat Aviv,
Israel). Nibrin-deficient human cells were obtained from the American
Type Culture Collection. Cells grown on coverslips were irradiated with
cesium-137 
 
 
 
 rays from a JL Shepherd and Associates 81–14R panoramic
irradiator at a dose rate of 1.35 Gy/min. UV IR was delivered in a single
pulse (50 J/m
 
2
 
) using a Stratalinker UV source (Stratagene). Before UV IR,
the culture medium was removed, and the medium was replaced immedi-
ately after IR. All cells were returned to the incubator for recovery and
harvested at the indicated times. Etoposide was used at 20 
 
 
 
g/ml for 20
min. To block cells in mitosis, cells were exposed to 0.04 
 
 
 
g/ml of no-
codazole for 15 h.
 
RNAi
 
RNAi was performed with siRNA that was commercially synthesized
(Dharmacon) and used as described in protocols provided by the manufac-
turer. Cells were treated with siRNA to a final concentration of 10 
 
 
 
M.
siRNA against HDAC6 was applied twice on consecutive days, whereas all
other siRNAs were applied once and harvested as described for each ex-
periment. Paired siRNA sequences targeting each protein were as follows:
HDAC4, GACGGGCCAGUGGUCACUG and CAGUGACCACUGGC-
CCGUC; 53BP1, CACACAGAUUGAGGAUACG and CGUAUCCUCA-
AUCUGUGUG; HDAC2, GCCUCAUAGAAUCCGCAUG and CAUGC-
GGAUUCUAUGAGGC; HDAC6, CCAGCCAGCGAAGAAGUAG and
CUACUUCUUCGCUGCCUGG. Control siRNA consisted of the unan-
nealed single-strand RNA and siRNA targeted against luciferase (both of
which did not affect levels of endogenous proteins).
 
Assays
 
HDAC assays were performed as previously described (Huang et al.,
2000). In brief, [
 
3
 
H]acetylated histones purified from HeLa cells (25,000
cpm/10 
 
 
 
g) were incubated with enzymes at 37
 
 
 
C for 15 min. The reac-
tion was stopped by the addition of concentrated HCl, extracted with 1 ml
of ethylacetate, and the amount of radioactivity released into the organic
layer was quantitated using a scintillation counter. In experiments in
which HDAC4 deacetylase activity was inhibited, HeLa cells were pre-
treated with 1 
 
 
 
M TSA. For immunoprecipitations, for each sample, 0.1 
 
 
 
g
of antibody or 10 
 
 l of preimmune rabbit serum was incubated with cell
lysate from 1.0   10
6 cells and incubated in the presence of ethidium bro-
mide (10  g/ml) to exclude nonspecific protein–DNA associations (Lai and
Herr, 1992). Cell preparation, image acquisition and processing, and
FACS
® analysis were as previously described (Kao et al., 1997, 2001). En-
dogenous mRNA was isolated using Trizol reagent (GIBCO BRL), as per
the manufacturer’s instructions, and assessed via RT-PCR. The Titan One
Tube RT-PCR System (Roche) was used with the following primers:
HDAC4, CAAGAACAAGGAGAAGGGCAAAG and GGACTCTGGTC-
AAGGGAACTG; 53BP1, AGGTGGGTGTTCTTTGGCTTCC and TTGGT-
GTTGAGGCTTGTGGTGATAC; glyceraldehyde-3-phosphate dehydroge-
nase, CAACTTTGGTATCGTGGAAGGACTC and AGGGATGATGTT-
CTGGAGAGCC (specific details regarding the PCR parameters used are
available from the authors).
Plating efficiency was defined as the proportion of cells that remained vi-
able 8 h after trypsinization and replating in fresh media. Cell viability was
assessed by trypan exclusion. Clonogenic survival assays were performed
as previously described (Biade et al., 2001), except that cells were counted
and plated 48 h after treatment with siRNA and colonies of at least 50 cells
were counted 14 d after plating. Statistical analyses were performed with
SPSS for Windows Release 10 and Microsoft Excel (Office 2000).
Online supplemental material
Additional data (Figs. S1–S4) regarding antibody specificity, Rad51 local-
ization after IR, and phosphorylated histone H3 (Pi-Histone H3) labeling
of siRNA-treated cells are available as supplemental material (http://
www.jcb.org/cgi/content/full/jcb.200209065/DC1).
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